<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.0 20120330//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1.dtd?><?SourceDTD.Version 1.0?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Gastroenterol Res Pract</journal-id><journal-id journal-id-type="iso-abbrev">Gastroenterol Res Pract</journal-id><journal-id journal-id-type="publisher-id">GRP</journal-id><journal-title-group><journal-title>Gastroenterology Research and Practice</journal-title></journal-title-group><issn pub-type="ppub">1687-6121</issn><issn pub-type="epub">1687-630X</issn><publisher><publisher-name>Hindawi</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">7666632</article-id><article-id pub-id-type="doi">10.1155/2020/4253174</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>
<italic>In Vitro</italic> Antioxidant, Anti-inflammatory, and <italic>In Vivo</italic> Anticolitis Effects of Combretin A and Combretin B on Dextran Sodium Sulfate-Induced Ulcerative Colitis in Mice</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0001-8586-6150</contrib-id><name><surname>Marius</surname><given-names>Mbiantcha</given-names></name><email>mbiantchamarius@yahoo.fr</email><xref ref-type="aff" rid="I1">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Amadou</surname><given-names>Dawe</given-names></name><xref ref-type="aff" rid="I2">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Donatien</surname><given-names>Atsamo Albert</given-names></name><xref ref-type="aff" rid="I3">
<sup>3</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Gilbert</surname><given-names>Ateufack</given-names></name><xref ref-type="aff" rid="I1">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>William</surname><given-names>Yousseu Nana</given-names></name><xref ref-type="aff" rid="I1">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Rauf</surname><given-names>Khalid</given-names></name><xref ref-type="aff" rid="I4">
<sup>4</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Arif</surname><given-names>Mehreen</given-names></name><xref ref-type="aff" rid="I4">
<sup>4</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Adeline</surname><given-names>Fanta Yadang Sabine</given-names></name><xref ref-type="aff" rid="I5">
<sup>5</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Saint</surname><given-names>Njoku Isaac</given-names></name><xref ref-type="aff" rid="I6">
<sup>6</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Dar</surname><given-names>Hamza</given-names></name><xref ref-type="aff" rid="I4">
<sup>4</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Rehman</surname><given-names>Naeem Ur</given-names></name><xref ref-type="aff" rid="I4">
<sup>4</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Ahmad</surname><given-names>Izhar</given-names></name><xref ref-type="aff" rid="I4">
<sup>4</sup>
</xref></contrib></contrib-group><aff id="I1">
<sup>1</sup>Laboratory of Animal Physiology and Phytopharmacology, Faculty of Science, University of Dschang, P.O. Box 67, Dschang, Cameroon</aff><aff id="I2">
<sup>2</sup>Department of Chemistry, Higher Teachers Training College, University of Maroua, P.O. Box 55, Maroua, Cameroon</aff><aff id="I3">
<sup>3</sup>Laboratory of Animal Physiology, Faculty of Science, University of Yaounde I, PO Box 812, Yaound'e, Cameroon</aff><aff id="I4">
<sup>4</sup>Department of Pharmacy, COMSATS University Islamabad, Abbottababd Campus, 22060 Abbottabad Khyber Pakhtunkhwa, Pakistan</aff><aff id="I5">
<sup>5</sup>Center for Research on Medicinal Plants and Traditional Medicine, Institute of Medical Research and Medicinal Plants Studies, P.O. Box 13033, Yaounde, Cameroon</aff><aff id="I6">
<sup>6</sup>Department of Chemistry, University of Lagos, Akoka, Lagos, Nigeria</aff><author-notes><fn fn-type="other"><p>Academic Editor: Paolo Gionchetti</p></fn></author-notes><pub-date pub-type="collection"><year>2020</year></pub-date><pub-date pub-type="epub"><day>7</day><month>11</month><year>2020</year></pub-date><volume>2020</volume><elocation-id>4253174</elocation-id><history><date date-type="received"><day>23</day><month>6</month><year>2020</year></date><date date-type="rev-recd"><day>30</day><month>8</month><year>2020</year></date><date date-type="accepted"><day>9</day><month>10</month><year>2020</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2020 Mbiantcha Marius et al.</copyright-statement><copyright-year>2020</copyright-year><license xlink:href="https://creativecommons.org/licenses/by/4.0/"><license-p>This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><p>
<italic>Combretum fragrans</italic> (Combretaceae) is a Cameroonian medicinal plant containing various secondary metabolites and traditionally used for the treatment of several pathologies. Two cycloartane-type triterpenes, Combretin A and Combretin B, were isolated from this plant. This study was aimed at evaluating the anti-inflammatory, antioxidant, and anticolitis effects of these compounds. <italic>In vitro</italic> anti-inflammatory properties were evaluated by inhibition of cyclooxygenase, 5-lipoxygenase, and denaturation of the protein; antioxidant properties were assessed by using 1,1-diphenyl-2-picrylhydrazyl (DPPH), (2,2'-azino-bis(3-ethylbenzthiazoline-6-sulphonic acid)) ABTS<sup>&#x02022;+</sup>, capacity tests ferric reducing antioxidant (FRAP), and trapping nitric oxide. For <italic>in vivo</italic> analysis, we used the model of ulcerative colitis induced by Dextran Sulfate Sodium (DSS). Studies of the anti-inflammatory activity showed that Combretin A and Combretin B had maximal inhibitory activity on cyclooxygenase (71.92% and 89.59%), 5-lipoxygenase (76.68% and 91.21%), and protein denaturation (63.93% and 87.78%). Antioxidant activity on DPPH, ABTS<sup>&#x02022;+</sup>, ferric reducing antioxidant capacity (FRAP), and nitric oxide scavenging showed that Combretin A and Combretin B showed good antioxidant activities. These compounds significantly reduced the signs of DSS-induced colitis in the treated animals by preventing the weight loss of the animals, by significantly reducing the disease activity index, improving the condition of the stool, preventing the reduction of the length of the colon, and preventing the degradation of the colon. This study revealed that Combretin A and Combretin B have anti-inflammatory, antioxidant, and curative properties against colitis experimentally induced by DSS in rats.</p></abstract><funding-group><award-group><funding-source>COMSATS University Islamabad</funding-source><award-id>3240287152</award-id></award-group><award-group><funding-source>The World Academy of Sciences</funding-source></award-group></funding-group></article-meta></front><body><sec id="sec1"><title>1. Introduction</title><p>Inflammatory bowel diseases, mainly represented by ulcerative colitis and Crohn's disease, are chronic pathologies of the cell-mediated digestive tract which are accompanied by significant recurrent and chronic inflammation [<xref rid="B1" ref-type="bibr">1</xref>]. People with inflammatory bowel disease present a significant dysfunction of the immune system [<xref rid="B2" ref-type="bibr">2</xref>], and COX plays a very important role in the development and maintenance of ulcerative colitis [<xref rid="B3" ref-type="bibr">3</xref>]. In mammals, COX has two isoforms, COX-1 which is constitutive and COX-2 which is induced by the inflammatory response [<xref rid="B3" ref-type="bibr">3</xref>]. During the pathophysiology of inflammatory bowel diseases, inflammatory lesions trigger innate immune responses resulting in the production of chemokines and cytokines (TNF-<italic>&#x003b1;</italic>, IL-6, IL-1<italic>&#x003b2;</italic>) by intestinal epithelium cells and the macrophages that will be responsible for the development of the adaptive immune system [<xref rid="B4" ref-type="bibr">4</xref>]. Thus, in the absence of treatment, intestinal lesions can occur following an exaggeration of the inflammatory response [<xref rid="B5" ref-type="bibr">5</xref>]. Numerous studies have shown that several natural compounds which have the capacity to inhibit the production of cytokines and the activity of COX-2 have an important therapeutic efficacy against inflammatory bowel diseases [<xref rid="B6" ref-type="bibr">6</xref>].</p><p>When our body is attacked by bacteria and viruses, the inflammatory process is activated with the production of white blood cells and other protective substances [<xref rid="B7" ref-type="bibr">7</xref>]. These inflammatory reactions set up to protect our organism which involves reactive oxygen species starting with the activation of leukocytes. Thus, the effect of a product for the modulation of inflammatory processes could be provided by its antioxidant properties [<xref rid="B8" ref-type="bibr">8</xref>]. The release of elements such as hydroxyl radicals, superoxide, and/or peroxyl radicals is responsible for the development of oxidative stress. These reactive oxygen species play a very important role in the pathophysiology of many diseases (coronary artery disease, neurodegenerative disorders, aging, atherosclerosis, inflammation, chronic pain, Alzheimer's disease, cancer, and cataracts) [<xref rid="B9" ref-type="bibr">9</xref>, <xref rid="B10" ref-type="bibr">10</xref>]. During the development of many inflammatory disorders, the phagocytes are activated; hydrogen peroxides (free radical species) such as the O<sub>2</sub> and &#x02219;OH radicals are released [<xref rid="B11" ref-type="bibr">11</xref>] and destroy the membrane by lipid peroxidation following a direct or indirect oxidative action. Tissue damage leads to the development of an inflammatory reaction with the production of chemotactic factors and numerous mediators [<xref rid="B12" ref-type="bibr">12</xref>].</p><p>In order to carry out scientific studies on inflammatory bowel disease, several animal models have been developed such as models transferred by adoption, chemically induced models, genetically modified models, and spontaneous models [<xref rid="B13" ref-type="bibr">13</xref>]. The DSS-induced colitis model (Dextran Sodium Sulfate), which is a very simple and reproducible model, is commonly used to assess the pathogenesis of ulcerative colitis and also to test new treatments potentially effective against ulcerative colitis [<xref rid="B14" ref-type="bibr">14</xref>]. Indeed, concerning this model, 1 to 5% of DSS is added to the drinking water which is given to the animals for several days; after a few days, animals develop symptoms such as diarrhea, loss of body weight, ulcers, bleeding, and mucosal lesions that are characteristics of human ulcerative colitis [<xref rid="B15" ref-type="bibr">15</xref>]. These symptoms can be relieved with many drug treatments; however, these different modern treatments have many side effects and increased tolerance in patients with ulcerative colitis [<xref rid="B16" ref-type="bibr">16</xref>]. For these different reasons, new therapeutic approaches remain to be developed and are currently necessary for the relief of people suffering from ulcerative colitis.</p><p>In the treatment of inflammatory disorders, a product capable of trapping reactive oxygen species, inhibiting the production of cytokines and COX, can be very beneficial. <italic>Combretum fragrans</italic> F. HOFFM (Combretaceae), a plant containing several classes of compounds such as saponins, steroids, flavonoids, triterpenes, and tannins [<xref rid="B17" ref-type="bibr">17</xref>, <xref rid="B18" ref-type="bibr">18</xref>], is used in Africa to treat diarrhea, leprosy, pain, cough, inflammation, and chronic diabetic wounds. Two cycloartane-type triterpenes named Combretin A and Combretin B were isolated from the leaves of this species and showed <italic>in vitro</italic> inhibitory properties for the production of NO, TNF alpha, ROS, and immunomodulatory properties; they also showed analgesic, anti-inflammatory, antihypernociceptive, and neuroprotective properties [<xref rid="B18" ref-type="bibr">18</xref>&#x02013;<xref rid="B20" ref-type="bibr">20</xref>]. However, the ability of Combretin A and Combretin B to inhibit the onset of symptoms of DSS-induced colitis has not been studied. The results of our previous work prompted us to check whether Combretin A and Combretin B could have anti-inflammatory activity in the model of DSS-induced ulcerative colitis in mice.</p></sec><sec id="sec2"><title>2. Methods</title><sec id="sec2.1"><title>2.1. Reagents, Chemicals, and Equipment</title><p>1,1-Diphenyl-2-picrylhydrazyl (DPPH) was obtained from Sigma Aldrich (St. Louis, MO, USA). Sodium nitroprusside was purchased from Merck Ltd., India, Mumbai. Phosphoric acid, sodium hydroxide, sodium linoleate, sulfanilamide, sulfuric acid, linoleic acid, ascorbic acid, and arachidonic acid were purchased from SD Fine Chem. Ltd, Mumbai. Thiobarbituric acid, lipopolysaccharide, hemoglobin, ethylenediaminetetraacetic acid, and bovine albumin were obtained from Central Drug House Pvt. Ltd., New Delhi. Trypsin and casein were obtained from Hi-Media Lab. Ltd., Mumbai. <italic>N</italic>-(1-naphthyl)ethylenediamine dihydrochloride, potassium persulfate, potassium phosphate buffer, glutathione, and benzene were obtained from LOBA CHEME Pvt. Ltd. Mumbai. The chemicals include the following products: methanol, dimethyl sulfoxide (DMSO), and sodium chloride and were purchased from Geochim Sarl, west region of Cameroon. DSS was purchased from Tokyo Chemical Industry Co., Ltd., Japan. Prednisolone (Solupred) and all other chemicals and reagents were pure analytical grade and obtained from local suppliers.</p></sec><sec id="sec2.2"><title>2.2. Plant Material, Extraction, and Isolation</title><p>The plant material, referenced to the national herbarium of Cameroon with number 30309/H.N.C. in the name of <italic>Combretum fragrans</italic> (Combretaceae), was used to isolate the pure compounds tested in this study. The fresh leaves of this plant were harvested in the city of Maroua located in the far north region (Cameroon) [<xref rid="B18" ref-type="bibr">18</xref>]. These leaves were macerated in methanol; the extract obtained was successively fractionated in hexane, AcOEt, and BuOH. AcOEt fraction was subjected to conventional separation methods, and the isolated compounds (Combretin A and Combretin B) were described by usual spectroscopic methods [<xref rid="B18" ref-type="bibr">18</xref>].</p></sec><sec id="sec2.3"><title>2.3. <italic>In Vitro</italic> Assay</title><p>To develop the methodology of the study, Nguemnang et al. [<xref rid="B21" ref-type="bibr">21</xref>] was briefly followed.</p><sec id="sec2.3.1"><title>2.3.1. Anti-inflammatory Activity</title><p>
<italic>(1) Inhibition of Protein Denaturation</italic>. For the evaluation of anti-inflammatory properties, the protocol described by Padmanabhan and Jangle [<xref rid="B22" ref-type="bibr">22</xref>] was used with some modifications. One milliliter of test compounds or diclofenac sodium in different concentrations (100, 200, 500, and 1000&#x02009;<italic>&#x003bc;</italic>g/mL) was added to 1&#x02009;mL aqueous solution of 5% bovine serum that was then incubated for 15 minutes at 27&#x000b0;C. Distilled water and BSA mixture were used as control. For protein denaturation, the whole mixture was placed at 70&#x000b0;C for about 10 minutes. When the mixture is cooled down to room temperature, the activity of each mixture was measured at 660&#x02009;nm. All tests were performed in triplicate. The following formula was used to study percent inhibition:
<disp-formula id="eq1"><label>(1)</label><mml:math id="M1"><mml:mtable><mml:mtr><mml:mtd><mml:mi>%</mml:mi><mml:mtext>Inhibition</mml:mtext><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mtext>Absorbance&#x02009;of&#x02009;control</mml:mtext><mml:mo>&#x02013;</mml:mo><mml:mtext>Absorbance&#x02009;of&#x02009;sample</mml:mtext></mml:mrow><mml:mrow><mml:mtext>Absorbance&#x02009;of&#x02009;control</mml:mtext></mml:mrow></mml:mfrac><mml:mo>&#x000d7;</mml:mo><mml:mn>100</mml:mn><mml:mo>.</mml:mo></mml:mtd></mml:mtr></mml:mtable></mml:math></disp-formula></p><p>
<italic>(2) Assay of Cyclooxygenase and 5-Lipoxygenase Inhibition</italic>. <bold>Lymphocyte culture preparation</bold>. For the culturing of human peripheral lymphocytes, RPMI 1640 (HIMEDIA) that was supplemented with streptomycin, penicillin, and fetal calf serum was used. Phytohemagglutinin (HIMEDIA) used mediated the cell proliferation. The culture was filtered (cellulose acetate 0.2&#x02009;<italic>&#x003bc;</italic>m pore, Sartorios) and incubated for 72 hours after the addition of plasma (1 &#x000d7; 10<sup>6</sup>&#x02009;cells/mL). This culture was then activated by adding lipopolysaccharide (1&#x02009;<italic>&#x003bc;</italic>L) and incubated for 24 hours. After activation, Combretin A, Combretin B, and diclofenac were added in different concentrations (100, 200, 500, and 1000&#x02009;<italic>&#x003bc;</italic>g/mL) and incubated for 24 hours. These are then centrifuged for 10 minutes at 6000&#x02009;rpm for sedimentation. The supernatant was removed, and cell lysis buffer was added (50&#x02009;<italic>&#x003bc;</italic>L) and again centrifuged at 6000&#x02009;rpm for 10 minutes [<xref rid="B23" ref-type="bibr">23</xref>].</p><p>
<bold>Assay of Cyclooxygenase</bold>. Cyclooxygenase assay was performed using Tris-HCl buffer, enzyme, hemoglobin, and glutathione. To this mixture, arachidonic acid and TCA (10% in 1&#x02009;N HCl, 0.2&#x02009;mL) were added and incubated for 20 minutes at 37&#x000b0;C. Then, to the mixture, TBA (0.2&#x02009;mL) was added and heated in boiling water for 20 minutes. This is then cooled and centrifuged for 3 minutes at 1000&#x02009;rpm. The supernatant was used to measure COX activity at 632&#x02009;nm [<xref rid="B23" ref-type="bibr">23</xref>].</p><p>
<bold>Assay of 5-lipoxygenase</bold>. Lipoxygenase assay was performed by mixing equal quantities of linoleic acid (70&#x02009;mg) and tween 20 in 4&#x02009;mL of nonoxygenated water. To this mixture, sodium hydroxide (0.5&#x02009;N) was added, and nonoxygenated water is added in a quantity sufficient to make a volume up to 25&#x02009;mL. The resulting solution will be divided into 0.5&#x02009;mL portions and thoroughly rinsed with nitrogen and then left for freezing. A quartz cuvette (25&#x000b0;C) with 1&#x02009;cm optical pathway made it possible to carry out a reaction. The optic density (OD) was measured at 234&#x02009;nm with a mixture containing sodium linoleate (0.2&#x02009;mL), Tris buffer (2.75&#x02009;mL, pH&#x02009;7.4), and enzyme (50&#x02009;mL) [<xref rid="B23" ref-type="bibr">23</xref>]. The percent inhibition was calculated by using the following equation:
<disp-formula id="eq2"><label>(2)</label><mml:math id="M2"><mml:mtable><mml:mtr><mml:mtd><mml:mi>%</mml:mi><mml:mtext>inhibition</mml:mtext><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mrow><mml:mtext>OD</mml:mtext></mml:mrow><mml:mrow><mml:mtext>control</mml:mtext></mml:mrow></mml:msub><mml:mo>&#x02212;</mml:mo><mml:msub><mml:mrow><mml:mtext>OD</mml:mtext></mml:mrow><mml:mrow><mml:mtext>sample</mml:mtext></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mtext>OD</mml:mtext></mml:mrow><mml:mrow><mml:mtext>control</mml:mtext></mml:mrow></mml:msub></mml:mrow></mml:mfrac><mml:mo>&#x000d7;</mml:mo><mml:mn>100</mml:mn><mml:mo>.</mml:mo></mml:mtd></mml:mtr></mml:mtable></mml:math></disp-formula></p></sec><sec id="sec2.3.2"><title>2.3.2. Antioxidant Activity</title><p>
<italic>(1) DPPH Radical Scavenging Activity</italic>. DPPH 24&#x02009;mg was dissolved in 100&#x02009;mL methanol; this solution is then diluted to a point to obtain absorbance at 517&#x02009;nm of about 0.98 &#x000b1; 0.02 forming a working solution. From this working solution, 3&#x02009;mL was mixed with 100&#x02009;<italic>&#x003bc;</italic>L of Combretin A, Combretin B, or standard solution (1&#x02009;mg/mL), and absorbance was measured (517&#x02009;nm for 30 minutes) [<xref rid="B24" ref-type="bibr">24</xref>]. The control contained 100&#x02009;<italic>&#x003bc;</italic>L methanol in place of the plant sample. The percentage of antiradical activity (antioxidant) was determined by the following formula:
<disp-formula id="eq3"><label>(3)</label><mml:math id="M3"><mml:mtable><mml:mtr><mml:mtd><mml:mi>%</mml:mi><mml:mtext>antioxidant&#x02009;activity</mml:mtext><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mtext>Absorbance</mml:mtext><mml:mfenced open="(" close=")"><mml:mrow><mml:mtext>control</mml:mtext></mml:mrow></mml:mfenced><mml:mo>&#x02013;</mml:mo><mml:mtext>Absorbance</mml:mtext><mml:mfenced open="(" close=")"><mml:mrow><mml:mtext>sample</mml:mtext></mml:mrow></mml:mfenced></mml:mrow><mml:mrow><mml:mtext>Absorbance</mml:mtext><mml:mfenced open="(" close=")"><mml:mrow><mml:mtext>control</mml:mtext></mml:mrow></mml:mfenced></mml:mrow></mml:mfrac><mml:mo>&#x000d7;</mml:mo><mml:mn>100</mml:mn><mml:mo>.</mml:mo></mml:mtd></mml:mtr></mml:mtable></mml:math></disp-formula></p><p>
<italic>(2) ABTS&#x02022;+ Decolorization Assay</italic>. ABTS (7&#x02009;mM) in a volume of 9.5&#x02009;mL was taken and mixed with 245&#x02009;<italic>&#x003bc;</italic>L of potassium persulfate (100&#x02009;mM) that is supplemented to 10&#x02009;mL with distilled water to form a working solution. This solution is left for 18 hours in dark at room temperature; after that, potassium phosphate buffer (0.1&#x02009;M, pH&#x02009;7.4) was introduced until an absorbance (734&#x02009;nm) of about 0.70 &#x000b1; 0.02 was obtained. The tested compounds were diluted in methanol to obtain concentrations of 0.1, 0.25, 0.5, and 1&#x02009;mg/mL. 10&#x02009;<italic>&#x003bc;</italic>L of a sample was mixed with 2.99&#x02009;mL of working solution and recorded at 734&#x02009;nm [<xref rid="B25" ref-type="bibr">25</xref>]. The control was prepared by adding 10&#x02009;<italic>&#x003bc;</italic>L of methanol in place of the sample. The percentage of antioxidant activity was determined using the following formula:
<disp-formula id="eq4"><label>(4)</label><mml:math id="M4"><mml:mtable><mml:mtr><mml:mtd><mml:mi>%</mml:mi><mml:mtext>antioxidant&#x02009;activity</mml:mtext><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mtext>Absorbance</mml:mtext><mml:mfenced open="(" close=")"><mml:mrow><mml:mtext>control</mml:mtext></mml:mrow></mml:mfenced><mml:mo>&#x02013;</mml:mo><mml:mtext>Absorbance</mml:mtext><mml:mfenced open="(" close=")"><mml:mrow><mml:mtext>sample</mml:mtext></mml:mrow></mml:mfenced></mml:mrow><mml:mrow><mml:mtext>Absorbance</mml:mtext><mml:mfenced open="(" close=")"><mml:mrow><mml:mtext>control</mml:mtext></mml:mrow></mml:mfenced></mml:mrow></mml:mfrac><mml:mo>&#x000d7;</mml:mo><mml:mn>100</mml:mn><mml:mo>.</mml:mo></mml:mtd></mml:mtr></mml:mtable></mml:math></disp-formula></p><p>
<italic>(3) Ferric Reducing Antioxidant Potential (FRAP)</italic>. The working reagent was prepared by mixing acetate buffer (25&#x02009;mL, 30&#x02009;mM, pH&#x02009;3.6), TPTZ (2.5&#x02009;mL, 10&#x02009;mM), and iron chloride (2.5&#x02009;mL, mM) and incubated at 37&#x000b0;C (15 minutes). Concentrations between 50&#x02009;mg/L and 500&#x02009;mg/L of ascorbic acid produced a calibration curve [<xref rid="B26" ref-type="bibr">26</xref>]. The absorbance was measured at 593&#x02009;nm for each specimen consisting of working reagent (2.85&#x02009;mL), test compounds (150&#x02009;<italic>&#x003bc;</italic>L, 0.1&#x02009;mg/mL) diluted in methanol, methanol (150&#x02009;<italic>&#x003bc;</italic>L), or stallion.</p><p>
<italic>(4) Nitric Oxide Scavenging Assay</italic>. Sodium nitroprusside (0.5&#x02009;mL, 5&#x02009;mmol/L, pH&#x02009;7.4) was combined at different concentrations 0.1, 0.25, 0.5, and 1&#x02009;mg/mL of test compounds, ascorbic acid, or an equivalent amount of methanol and incubated for 180 minutes (25&#x000b0;C). Griess reagent (1.5&#x02009;mL) consisting of sulfanilamide (1%), phosphoric acid (2%), and <italic>N</italic>-1-naphthylethylenediamine dihydrochloride (0.1%) was added, and the mixture was again incubated for 30 minutes. Absorbance was measured at 546&#x02009;nm, and the percentage of activity was determined relative to the standard [<xref rid="B27" ref-type="bibr">27</xref>]. The following equation was used to show percent inhibition:
<disp-formula id="eq5"><label>(5)</label><mml:math id="M5"><mml:mtable><mml:mtr><mml:mtd><mml:mi>%</mml:mi><mml:mtext>nitric&#x02009;oxide&#x02009;scavenging</mml:mtext><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mtext>Absorbance&#x02009;of&#x02009;control</mml:mtext><mml:mo>&#x02013;</mml:mo><mml:mtext>Absorbance&#x02009;of&#x02009;test</mml:mtext></mml:mrow><mml:mrow><mml:mtext>Absorbance&#x02009;of&#x02009;control</mml:mtext></mml:mrow></mml:mfrac><mml:mo>&#x000d7;</mml:mo><mml:mn>100</mml:mn><mml:mo>.</mml:mo></mml:mtd></mml:mtr></mml:mtable></mml:math></disp-formula></p></sec></sec><sec id="sec2.4"><title>2.4. <italic>In Vivo</italic> Assay</title><sec id="sec2.4.1"><title>2.4.1. Experimental Animals</title><p>The blind behavioral evaluation technique was performed for the administration of different treatments. Mice (males and females), aged about 3 months and weighing between 25 and 30&#x02009;g, reared in an animal house (controlled temperature (22 &#x000b1; 1&#x000b0;C) and a 12-hour light cycle/12&#x02009;h in dark, with standard laboratory food and unlimited water) from the National Institutes of Health (NIH) Islamabad, Pakistan, were used for this test.</p><p>The minimum number of mice (6 animals per group) was granted by the National Institute of Health Institute (IACUC) Committee of National Institute of Health. In addition, the study protocols accepted by the Ethics Committee of the National Institute of Health Islamabad in Pakistan were used to assess the consistency of the effects of different treatments administered.</p></sec><sec id="sec2.4.2"><title>2.4.2. Experimental Colitis</title><p>For the induction of experimental colitis, 4% DSS was used. Briefly, after an habituation period of one week, mice (42) were randomly divided into 7 groups (6 mice/group): untreated (no DSS), 4% DSS+2.5% DMSO/2.5% tween, 4% DSS+prednisolone (4&#x02009;mg/kg), 4% DSS+Combretin A (25&#x02009;mg/kg), 4% DSS+Combretin A (50&#x02009;mg/kg), 4% DSS+Combretin B (25&#x02009;mg/kg), and 4% DSS+Combretin B (50&#x02009;mg/kg). The untreated group received distilled water without DSS. For other groups, water bottles were filled with 4% DSS. Combretin A, Combretin B, prednisolone, and distilled water were administered orally from the 5<sup>th</sup> day after the onset of colitis induction by DSS.</p><p>Mice were scored daily for 10 days based on body weight and stool formation (bloody or nonbloody). Stool formation, bloody stool scores, and weight loss were averaged to determine the Disease Activity Index (DAI). Scores were assessed as follows: bloody stools (0: negative, 2: positive, or 4: gross bleeding), weight change (0: &#x0003c;1%, 1: 1&#x02013;5%, 2: 5&#x02013;10%, 3: 10&#x02013;15%, or 4: &#x0003e;15%), and stool formation (0: normal, 2: loose stools, or 4: diarrhea). On day 10, the mice were sacrificed under ether vapor anesthesia and the intestines were isolated [<xref rid="B28" ref-type="bibr">28</xref>].</p><p>The entire colon from the ileocolic junction to the anus was quickly removed, opened longitudinally along the mesenteric fixation line, then washed with saline in a reservoir of ice water and dried with filter paper; then, the total length of the two points was measured [<xref rid="B29" ref-type="bibr">29</xref>].</p></sec><sec id="sec2.4.3"><title>2.4.3. Macroscopic and Microscopic Evaluation of the Colon</title><p>The same colon removed, washed, and dried was photographed using a Canon camera (Cyber-shot, 7.2 megapixels, China); then, the samples from this colon were fixed in 10% formalin buffered with PBS. The sections were made in pieces of 5&#x02009;<italic>&#x003bc;</italic>m each; then, staining was done with hematoxylin-eosin (H&#x00026;E) [<xref rid="B29" ref-type="bibr">29</xref>].</p></sec></sec><sec id="sec2.5"><title>2.5. Statistical Analysis</title><p>All the data from <italic>in vitro</italic> tests indicate an average &#x000b1; SEM of triplicate. The differences between groups were assessed by one way ANOVA followed by the Tukey posttest; for <italic>in vivo</italic> test, data are presented in the form of an average of 6 mice &#x000b1; SEM, and the differences between groups were evaluated by ANOVA (two way) followed by Bonferroni posttest and ANOVA (one way) followed by Tukey's posttest. Significant differences were considered at <italic>p</italic> &#x0003c; 0.05.</p></sec></sec><sec id="sec3"><title>3. Results</title><sec id="sec3.1"><title>3.1. <italic>In Vitro</italic> Activity</title><sec id="sec3.1.1"><title>3.1.1. Anti-inflammatory Activity</title><p>
<italic>(1) Inhibition of Protein Denaturation</italic>. Based on the results of this study, Combretin A and B effectively inhibited protein denaturation caused by heat. <xref rid="tab1" ref-type="table"> Table 1</xref> thus shows a significant (<italic>p</italic> &#x0003c; 0.001) inhibition of 63.93% and 87.78%, respectively, for Combretin A and B while diclofenac sodium at 1000&#x02009;<italic>&#x003bc;</italic>g/mL produced an inhibition of 89.20%.</p><p>
<italic>(2) Cyclooxygenase Inhibitory Assay</italic>. Evaluation of cyclooxygenase activity determined the effect of both compounds on prostaglandin production. The results show that, at 1000&#x02009;<italic>&#x003bc;</italic>g/mL, Combretin A and B and Diclofenac sodium significantly inhibited (<italic>p</italic> &#x0003c; 0.001) the cyclooxygenase activity with 71.92%, 89.59%, and 97.88%, respectively (<xref rid="tab1" ref-type="table">Table 1</xref>).</p><p>
<italic>(3) 5-Lipoxygenase Inhibitory Assay</italic>. The evaluation of the activity of 5-lipoxygenase was used to study the effect of the compounds on the production of leukotrienes. It appears from this table that Combretin A and B, as well as diclofenac sodium, have a significant effect (<italic>p</italic> &#x0003c; 0.001) on 5-lipoxygenase activity with an inhibition of 76.68%, 91.21%, and 95.31%, respectively (<xref rid="tab1" ref-type="table">Table 1</xref>).</p></sec><sec id="sec3.1.2"><title>3.1.2. Anti-oxidant Activity</title><p>
<italic>(1) ABTS&#x02022;+ Radical Decolorization Assay</italic>. It appears from <xref ref-type="fig" rid="fig1">Figure 1(a)</xref> that Combretin A and B and vitamin C (used as a reference substance) showed significant antioxidant activity on the relative recovery capacity of ABTS generated in the aqueous phase.</p><p>
<italic>(2) DPPH Radical Scavenging Activity</italic>. The results presented in <xref ref-type="fig" rid="fig1">Figure 1(b)</xref> show the activity of Combretin A and B in free radical scavenging by the DPPH test. It appears that Combretin A and B and vitamin C at the concentration of 1&#x02009;mg/mL showed a significant activity (<italic>p</italic> &#x0003c; 0.001) with inhibition percentages, respectively, of 91.38%, 57.83%, and 95.15%.</p><p>
<italic>(3) Ferric Reducing Antioxidant Potential (FRAP)</italic>. The antioxidant capacity of Combretin A and B was determined using the FRAP assay (<xref ref-type="fig" rid="fig1">Figure 1(c)</xref>). Combretin B showed the highest and most significant antioxidant capacity (<italic>p</italic> &#x0003c; 0.001), followed by Combretin A. Both compounds exhibited a similar upward trend in activity with an increased concentration.</p><p>
<italic>(4) Nitric Oxide Scavenging Assay</italic>. <xref rid="tab2" ref-type="table"> Table 2</xref> shows the comparison between the inhibition percentages of the compounds tested with ascorbic acid. This table shows that Combretin B activity was significantly greater than that of Combretin A in nitric oxide scavenging and that the activities of both compounds increased with increasing dose.</p></sec></sec><sec id="sec3.2"><title>3.2. <italic>In Vivo</italic> Activity</title><sec id="sec3.2.1"><title>3.2.1. Effect of Combretin A and Combretin B on Body Weight</title><p>In the group treated with DSS, the recorded weight loss was significant (<italic>p</italic> &#x0003c; 0.001) from day 4 after administration of DSS (4%), and this loss remained significant (<italic>p</italic> &#x0003c; 0.001) until day 10. Treatment with Combretin A and B (25 and 50&#x02009;mg/kg) reversed weight loss from day 7. The effect of Combretin A and B (50&#x02009;mg/kg) was greater than that of prednisolone (4&#x02009;mg/kg), used as a reference substance (<xref ref-type="fig" rid="fig2">Figure 2(a)</xref>).</p></sec><sec id="sec3.2.2"><title>3.2.2. Effect of Combretin A and Combretin B on the Disease Activity Index</title><p>The disease activity index scores increased significantly (<italic>p</italic> &#x0003c; 0.001) in all animals treated with DSS from the 2<sup>nd</sup> day, as indicated by the incidence of diarrhea, weight loss, and bloody stools. However, Combretin A and B (50&#x02009;mg/kg) and prednisolone (4&#x02009;mg/kg) showed significant (<italic>p</italic> &#x0003c; 0.001) reduction of the severity of DSS-induced disease (<xref ref-type="fig" rid="fig2">Figure 2(b)</xref>).</p></sec><sec id="sec3.2.3"><title>3.2.3. Effect of Combretin A and Combretin B on Stool Condition</title><p>
<xref ref-type="fig" rid="fig2">Figure 2(c)</xref> shows the stool condition of animals treated with Combretin A and B (25 and 50&#x02009;mg/kg) and prednisolone (4&#x02009;mg/kg). It appears that the score increased significantly (<italic>p</italic> &#x0003c; 0.001) in all the animals treated on day 1 after the induction of colitis compared to the animals in the normal control group. On the 7<sup>th</sup> day, the score of animals treated with the different compounds and with prednisolone was significant (<italic>p</italic> &#x0003c; 0.001) compared to that of animals in the negative control group. In addition, the effect of Combretin A and B (50&#x02009;mg/kg) was greater than that of prednisolone.</p></sec><sec id="sec3.2.4"><title>3.2.4. Effect of Combretin A and Combretin B on the Length of the Colon</title><p>Regarding the length of the colon, we found that the colon was significantly (<italic>p</italic> &#x0003c; 0.001) shorter in the negative control than in the normal control. Interestingly, treatment with Combretin A and B (50&#x02009;mg/kg, <italic>p</italic> &#x0003c; 0.001) and prednisolone (4&#x02009;mg/kg, <italic>p</italic> &#x0003c; 0.01) prevented the shortening of the colon significantly (<xref ref-type="fig" rid="fig3">Figure 3(a)</xref>).</p></sec><sec id="sec3.2.5"><title>3.2.5. Macroscopic Assessment of Colon Damage</title><p>
<xref ref-type="fig" rid="fig3">Figure 3(b)</xref> shows the macroscopic presentation of the intestine of the animals after the induction of colitis induced by DSS. DSS is found to cause bleeding development in animals in the negative control group. In contrast, the animals that received Combretin A and B (50&#x02009;mg/kg) and prednisolone show no bleeding.</p></sec><sec id="sec3.2.6"><title>3.2.6. Effect of Combretin A and Combretin B on the Histopathological Score</title><p>We next performed a histological analysis by performing H&#x00026;E staining. As shown in Figures <xref ref-type="fig" rid="fig4">4(a)</xref> and <xref ref-type="fig" rid="fig4">4(b)</xref>, 4% DSS treatment induced an inflammatory response that affected colonic architecture, cell infiltration, crypt shortening or loss, and goblet cell depletion. Administration of Combretin A (50&#x02009;mg/kg), Combretin B (50&#x02009;mg/kg), and prednisolone (4&#x02009;mg/kg) significantly reduced the number of infiltrating cells, mucosal injury, and bleeding.</p><p>Histological examination of the colonic sections under light microscopy revealed that the untreated DSS mice exhibited typical inflammatory changes in the colonic architecture; the damage was assessed from histopathological scores for the colon (range 0 to 9). Compared with the normal control, the negative control mice showed a significant increase in the histopathological score of the disease (<xref ref-type="fig" rid="fig4">Figure 4</xref>). After treatment with Combretin A and B (25 and 50&#x02009;mg/kg) and prednisolone (4&#x02009;mg/kg), the histopathological score of the disease decreased considerably showing a protective effect of the compounds against damage caused by DSS.</p></sec></sec></sec><sec id="sec4"><title>4. Discussion</title><p>In the present study, the results indicate that Combretin A and B possess good anti-inflammatory properties; however, Combretin B showed the best anti-inflammatory activity on several <italic>in vitro</italic> models such as inhibition of protein denaturation, inhibition of 5-LOX, and COX inhibition. Several anti-inflammatory drugs such as diclofenac, phenylbutazone, salicylic acid, and many more have shown an important ability to dose-dependently inhibit heat-induced protein denaturation [<xref rid="B30" ref-type="bibr">30</xref>]. The denaturation mechanism is involved in the alteration of electrostatic force, hydrogen, hydrophobic, and disulfide bonds [<xref rid="B31" ref-type="bibr">31</xref>]. Steroidal and nonsteroidal anti-inflammatory drugs, commonly used for the management of inflammatory conditions, have the ability to bind to plasma albumin, preventing or inhibiting thermal denaturation of albumin [<xref rid="B32" ref-type="bibr">32</xref>]. Thus, in this study, diclofenac, used as a reference substance, significantly inhibited the denaturation of proteins. Known as a truly complex physiopathological response, inflammation involves a large production of free radicals derived from neutrophils, nitric oxide (NO), reactive oxygen species (ROS), prostaglandins, and cytokines during its process [<xref rid="B33" ref-type="bibr">33</xref>]. The pathogenesis of inflammatory diseases involves the overproduction of substances such as prostaglandin I2, prostaglandin E2, thromboxane A2, and leukotrienes from arachidonic acid through two metabolic pathways, the COX (cyclooxygenase) pathway and the 5-LOX (5-lipoxygenase) pathway [<xref rid="B34" ref-type="bibr">34</xref>]. Substances capable of inhibiting the activities of COX and 5-LOX resulting in a significant reduction in the production of leukotrienes and prostaglandins produce a large spectrum of anti-inflammatory activity and can be considered as having an excellent pharmacological safety profile in the clinic [<xref rid="B35" ref-type="bibr">35</xref>]. Ibuprofen, a nonsteroidal anti-inflammatory drug, is an inhibitor of COX which rapidly and reversibly and/or irreversibly seizes the active site of COX and acts as a competitive inhibitor of arachidonic acid oxygenation [<xref rid="B36" ref-type="bibr">36</xref>&#x02013;<xref rid="B38" ref-type="bibr">38</xref>]. The inhibitory activity of Combretin A and B on protein denaturation, the cyclooxygenase pathway, and 5-lipoxygenase show that these two compounds are capable of significantly inhibiting the production of prostaglandins and leukotrienes, which confers to these two compounds anti-inflammatory properties. In addition, our previous work has shown that Combretin A and B are able to inhibit carrageenan-induced inflammation in rats <italic>in vivo</italic> and to inhibit the production of ROS, TNF-<italic>&#x003b1;</italic>, and NO <italic>in vitro</italic> [<xref rid="B19" ref-type="bibr">19</xref>].</p><p>Antioxidant substances as well as free radical scavengers are very often used to mitigate certain inflammatory pathologies; since, during the inflammatory process, there is a large production of free radicals that have the power to maintain the skin process [<xref rid="B39" ref-type="bibr">39</xref>]. In this study, several tests were used to evaluate the antioxidant activity of Combretin A and B; it was to put in the presence of compounds the reaction of the Fe<sup>3+</sup>/ferricyanide complex reduction in a ferrous form (ABTS test), the ion reduction reaction compounds with the formation of a ferric tripyridyltriazine complex (Fe<sup>2+</sup>-TPTZ) (FRAP test), and the radical reduction reaction DPPH [<xref rid="B40" ref-type="bibr">40</xref>, <xref rid="B41" ref-type="bibr">41</xref>]. Combretin A and B showed a very important antioxidant capacity in all test models used with a concentration-dependent activity. During the development of the inflammatory process, macrophages are activated with overproduction of NO from nitric oxide synthase (iNOS) which will be responsible for an increase in vasodilation, vascular permeability, endothelial and tissue lesions, and development of inflammation. In addition to its important proinflammatory role in the development of chronic inflammation, NO is a diffusible free radical, considered a pleiotropic inhibitor in neuronal signaling, regulation of cell-mediated toxicity, relaxation of smooth muscle, platelet inhibition, and as an effector molecule in biological systems such as antimicrobial and antitumor activities, neuronal messages, or vasodilation [<xref rid="B42" ref-type="bibr">42</xref>]. From this study, Combretin A and B significantly reduced the amount of nitrite produced by the decomposition of sodium nitroprusside <italic>in vitro</italic>, suggesting that the direct NO scavenging process may be responsible for NO deletion by both compounds.</p><p>In the present study, the administration of 4% DSS in drinking water led to the development of symptoms of ulcerative colitis (bloody diarrhea, weight loss, and shortening of the length of the colon) in all the mice in the group untreated; moreover, mice having received DSS and untreated also presented a higher DAI score and a histopathological score compared to normal mice. In this study, we showed that Combretin A and B inhibited experimental colitis, resulting in an overall attenuation of DAI inflammation, including colon length and changes in body weight. Oral administration of 4% DSS in mice causes acute colitis. Animals have shown a variety of clinical symptoms of inflammatory bowel disease, including diarrhea, bloody stools, and weight loss. A disease activity index score was used as a reliable tool to assess the extent of gastrointestinal disease in experimental DSS-induced colitis. At the end of the experimental period, clinical symptoms were more pronounced. Prednisolone used in this study as the reference drug exerts its anti-inflammatory and immunosuppressive effect by inducing the gene expression of annexin therefore which have the main function the inhibition of the phospholipase A2 enzyme with the consequence of suppressing the synthesis of prostaglandins and leukotrienes by the arachidonic acid. Prednisolone can also act on macrophages and monocytes by blocking the synthesis and release of many proinflammatory cytokines (interleukin 1 (IL-1), interleukin 6 (IL-6), and tumor necrosis factor-<italic>&#x003b1;</italic> (TNF-<italic>&#x003b1;</italic>)) [<xref rid="B43" ref-type="bibr">43</xref>]. In the study, prednisolone significantly reduced all the symptoms of DSS-induced colitis. However, mice treated with Combretin A and B significantly improved the clinical score, suggesting a protective effect of these compounds in this model of colitis. Histological scores indicate that treatment with Combretin A and B reduced the damage to the mucous membranes. Ultimately, the results obtained indicate that treatment with Combretin A and B effectively attenuates established colonic inflammation and has a pronounced protective effect against colitis induced by DSS in mice.</p><p>Many cytokines such as TNF-<italic>&#x003b1;</italic>, IL-6, and IL-1<italic>&#x003b2;</italic> play a key role in the pathogenicity of inflammatory bowel disease, in regulating inflammation of the intestinal mucosa, and in the integrity of the intestinal epithelium [<xref rid="B44" ref-type="bibr">44</xref>, <xref rid="B45" ref-type="bibr">45</xref>]. In addition, in people suffering from ulcerative colitis, the levels of TNF-<italic>&#x003b1;</italic>, IL-6, and IL-1<italic>&#x003b2;</italic> are greatly increased in the mucosa and serum [<xref rid="B46" ref-type="bibr">46</xref>]. Several studies have also shown that COX-2 expression is significantly elevated in animals with ulcerative colitis [<xref rid="B47" ref-type="bibr">47</xref>]. In addition, COX-2 and iNOS, known as inducible enzymes expressed rapidly by mononuclear macrophages, fibroblasts, or other cells after being stimulated in the body, are closely associated with the pathogenesis of ulcerative colitis. When iNOS and COX-2 are excessively released, oxidative damage can occur [<xref rid="B48" ref-type="bibr">48</xref>]. Likewise, ulcerative colitis is a peroxidative disease of the colon, and there are many intestinal pathological changes associated with the colitis process [<xref rid="B49" ref-type="bibr">49</xref>]. Oxidative stress is a response of the body stimulated by DSS. It can suppress endogenous defense systems that regulate the production of ROS [<xref rid="B50" ref-type="bibr">50</xref>]. High levels of ROS would have caused oxidative stress and DNA damage due to an imbalance between innate and exogenous antioxidants and ROS [<xref rid="B51" ref-type="bibr">51</xref>]. For these different reasons, several studies have shown that the regulation of these different pathways can be a solution for new therapeutic approaches against ulcerative colitis; thus, resveratrol exerts its effect against ulcerative colitis by increasing the expression of the SIRT1 gene, inducing the drop in the expression of p-IkB<italic>&#x003b1;</italic> as well as of COX-2 [<xref rid="B52" ref-type="bibr">52</xref>], while proto-catechic acid inhibits the production of inflammatory cytokines as well as COX-2 and iNOS to relieve patients with ulcerative colitis [<xref rid="B53" ref-type="bibr">53</xref>]. In previous studies, Combretin A and Combretin B have shown their ability to inhibit the production of NO, TNF alpha, and ROS, as well as their immunomodulatory properties [<xref rid="B19" ref-type="bibr">19</xref>], while in the present study, Combretin A and B have shown anti-inflammatory and antioxidant properties. These results suggest that the effect of Combretin A and Combretin B against DSS-induced ulcerative colitis may be closely associated with their regulatory effect on inflammatory cytokines, iNOS activity, COX-2 expression, ROS, and the antioxidant system.</p></sec><sec id="sec5"><title>5. Conclusion</title><p>The anti-inflammatory and antioxidant properties <italic>in vitro</italic>, followed by the <italic>in vivo</italic> anticolitic properties of Combretine A and B, were demonstrated in this study. The anti-inflammatory potentials of Combretin A and Combretin B were clearly described in the test for inhibition of denaturation of proteins, cyclooxygenase, and 5-lipoxygenase. The potential for trapping antioxidants and free radicals is clearly revealed in the DPPH, ABTS<sup>&#x02022;+</sup>, power reduction, and nitric oxide trapping tests. We have shown that Combretin A and Combretin B exert an inhibitory effect on the pathogenesis of colitis, improving colon shortening, body weight, DAI, and histopathological scores in mice with DSS-induced colitis.</p></sec></body><back><ack><title>Acknowledgments</title><p>The authors would like to thank the study participants. The authors wish to express their gratitude to TWAS (Academy of Science of Developing Countries) and COMSATS Institute of Information Technology staff members for the <italic>in vitro</italic> part. This manuscript research project was supported by the TWAS (Academy of Science of Developing Countries) and the COMSATS University Islamabad, under the Postdoctoral Fellowship Award to Mbiantcha Marius (RF no: 3240287152).</p></ack><glossary><title>Abbreviations</title><def-list><def-item><term>5-LOX:</term><def><p>5-Lipoxygenase</p></def></def-item><def-item><term>ANOVA:</term><def><p>Analysis of variance</p></def></def-item><def-item><term>COX:</term><def><p>Cyclooxygenase</p></def></def-item><def-item><term>DAI:</term><def><p>Disease activity index</p></def></def-item><def-item><term>DMSO:</term><def><p>Dimethyl sulfoxide</p></def></def-item><def-item><term>DPPH:</term><def><p>1,1-Diphenyl-2-picrylhydrazyl</p></def></def-item><def-item><term>DSS:</term><def><p>Dextran sulfate sodium</p></def></def-item><def-item><term>ECACC:</term><def><p>European collection of cell cultures</p></def></def-item><def-item><term>FRAP:</term><def><p>Ferric reducing antioxidant capacity</p></def></def-item><def-item><term>H &#x00026; E:</term><def><p>Hematoxylin and eosin</p></def></def-item><def-item><term>IL:</term><def><p>Interleukin</p></def></def-item><def-item><term>NIH:</term><def><p>National Institutes of Health</p></def></def-item><def-item><term>NO:</term><def><p>Nitrite oxide</p></def></def-item><def-item><term>OD:</term><def><p>Optic density</p></def></def-item><def-item><term>ROS:</term><def><p>Reactive oxygen species</p></def></def-item><def-item><term>TNF-<italic>&#x003b1;</italic>:</term><def><p>Tumor necrosis factor alpha.</p></def></def-item></def-list></glossary><sec sec-type="data-availability"><title>Data Availability</title><p>The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.</p></sec><sec><title>Ethical Approval</title><p>To demonstrate the coherent effects of our different compounds, the minimum possible of animals as the intensity of nociceptive stimuli was used. All tests were achieved using mature male and female mice (3 months old; 25&#x02013;35&#x02009;g), bred in the animal house facility (controlled temperature (22 &#x000b1; 1&#x000b0;C); 12&#x02009;h light/12&#x02009;h dark cycle with standard lab chow and water <italic>ad libitum</italic>) of the National Institute of Health (NIH), Islamabad, Pakistan. The treatment of animals was in agreement with the Institutional Animal Care and Use Committee (IACUC) of the National Institute of Health, and the study protocols accepted by the ethics committee of National Institute of Health, Islamabad, Pakistan.</p></sec><sec sec-type="COI-statement"><title>Conflicts of Interest</title><p>Mbiantcha Marius, Dawe Amadou, Atsamo Albert Donatien, Ateufack Gilbert, Yousseu Nana William, Khalid Rauf, Mehreen Arif, Fanta Yadang Sabine Adeline, Njoku Isaac Saint, Hamza Dar, Naeem Ur Rehman, and Izhar Ahmad have no conflicts of interest or financial ties to disclose.</p></sec><sec><title>Authors' Contributions</title><p>MM, DA, KR, and AAD designed and performed the study and performed the procedures. MM, AG, MA, FYSA, and NIS collected and analyzed the data. MM, YNW, HD, NUR, and IA drafted the manuscript and revised it critically. The authors read and approved the final manuscript.</p></sec><ref-list><ref id="B1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Geier</surname><given-names>M. S.</given-names></name><name><surname>Butler</surname><given-names>R. N.</given-names></name><name><surname>Howarth</surname><given-names>G. S.</given-names></name></person-group><article-title>Inflammatory bowel disease: current insights into pathogenesis and new therapeutic options; probiotics, prebiotics and synbiotics</article-title><source><italic toggle="yes">International Journal of Food Microbiology</italic></source><year>2007</year><volume>115</volume><issue>1</issue><fpage>1</fpage><lpage>11</lpage><pub-id pub-id-type="doi">10.1016/j.ijfoodmicro.2006.10.006</pub-id><pub-id pub-id-type="other">2-s2.0-33847345567</pub-id><?supplied-pmid 17137666?><pub-id pub-id-type="pmid">17137666</pub-id></element-citation></ref><ref id="B2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Y. Z.</given-names></name><name><surname>Li</surname><given-names>Y. Y.</given-names></name></person-group><article-title>Inflammatory bowel disease: pathogenesis</article-title><source><italic toggle="yes">World Journal of Gastroenterology</italic></source><year>2014</year><volume>20</volume><issue>1</issue><fpage>91</fpage><lpage>99</lpage><pub-id pub-id-type="doi">10.3748/wjg.v20.i1.91</pub-id><pub-id pub-id-type="other">2-s2.0-84891815184</pub-id><?supplied-pmid 24415861?><pub-id pub-id-type="pmid">24415861</pub-id></element-citation></ref><ref id="B3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shin</surname><given-names>E. J.</given-names></name><name><surname>Sung</surname><given-names>M. J.</given-names></name><name><surname>Yang</surname><given-names>H. J.</given-names></name><name><surname>Kim</surname><given-names>M. S.</given-names></name><name><surname>Hwang</surname><given-names>J. T.</given-names></name></person-group><article-title>Boehmeria nivea attenuates the development of dextran sulfate sodium-induced experimental colitis</article-title><source><italic toggle="yes">Mediator of Inflammation</italic></source><year>2014</year><volume>2014, article 231942</volume><fpage>7</fpage><pub-id pub-id-type="doi">10.1155/2014/231942</pub-id><pub-id pub-id-type="other">2-s2.0-84904131400</pub-id></element-citation></ref><ref id="B4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rieder</surname><given-names>F.</given-names></name><name><surname>Karrasch</surname><given-names>T.</given-names></name><name><surname>Ben-Horin</surname><given-names>S.</given-names></name><etal/></person-group><article-title>Results of the 2nd scientific workshop of the ECCO (III): basic mechanisms of intestinal healing</article-title><source><italic toggle="yes">Journal of Crohn's and Colitis</italic></source><year>2012</year><volume>6</volume><issue>3</issue><fpage>373</fpage><lpage>385</lpage><pub-id pub-id-type="doi">10.1016/j.crohns.2011.11.009</pub-id><pub-id pub-id-type="other">2-s2.0-84858079585</pub-id><?supplied-pmid 22405177?><pub-id pub-id-type="pmid">22405177</pub-id></element-citation></ref><ref id="B5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blumberg</surname><given-names>R. S.</given-names></name></person-group><article-title>Inflammation in the intestinal tract: pathogenesis and treatment</article-title><source><italic toggle="yes">Digestive Diseases</italic></source><year>2009</year><volume>27</volume><issue>4</issue><fpage>455</fpage><lpage>464</lpage><pub-id pub-id-type="doi">10.1159/000235851</pub-id><pub-id pub-id-type="other">2-s2.0-70449493484</pub-id><pub-id pub-id-type="pmid">19897960</pub-id></element-citation></ref><ref id="B6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Algieri</surname><given-names>F.</given-names></name><name><surname>Rodriguez-Nogales</surname><given-names>A.</given-names></name><name><surname>Garrido-Mesa</surname><given-names>N.</given-names></name><etal/></person-group><article-title>Intestinal anti-inflammatory activity of the <italic>Serpylli herba</italic> extract in experimental models of rodent colitis</article-title><source><italic toggle="yes">Journal of Crohn's and Colitis</italic></source><year>2014</year><volume>8</volume><issue>8</issue><fpage>775</fpage><lpage>788</lpage><pub-id pub-id-type="doi">10.1016/j.crohns.2013.12.012</pub-id><pub-id pub-id-type="other">2-s2.0-84904515594</pub-id><?supplied-pmid 24411672?><pub-id pub-id-type="pmid">24411672</pub-id></element-citation></ref><ref id="B7"><label>7</label><element-citation publication-type="confproc"><person-group person-group-type="author"><name><surname>Srividya Chandra</surname><given-names>M.</given-names></name></person-group><article-title>In vitro anti-inflammatory activity of some wild fruits of Karnataka</article-title><conf-name>Biological, Environment and Food Engineering-2015</conf-name><conf-date>2015</conf-date><fpage>48</fpage><lpage>50</lpage></element-citation></ref><ref id="B8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Uma</surname><given-names>S. A.</given-names></name><name><surname>Bharti</surname><given-names>O.</given-names></name></person-group><article-title>In-vitro 5-lipoxygenase inhibition of polyphenolic antioxidants from undomesticated plants of South Africa</article-title><source><italic toggle="yes">Journal of Medicinal Plant Research</italic></source><year>2008</year><volume>2</volume><fpage>207</fpage><lpage>212</lpage></element-citation></ref><ref id="B9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Burns</surname><given-names>J.</given-names></name><name><surname>Gardner</surname><given-names>P. T.</given-names></name><name><surname>Matthews</surname><given-names>D.</given-names></name><name><surname>Duthie</surname><given-names>G. G.</given-names></name><name><surname>Lean</surname><given-names>M. E.</given-names></name><name><surname>Crozier</surname><given-names>A.</given-names></name></person-group><article-title>Extraction of phenolics and changes in antioxidant activity of red wines during vinification</article-title><source><italic toggle="yes">Journal of Agricultural and Food Chemistry</italic></source><year>2001</year><volume>49</volume><issue>12</issue><fpage>5797</fpage><lpage>5808</lpage><pub-id pub-id-type="doi">10.1021/jf010682p</pub-id><pub-id pub-id-type="other">2-s2.0-0035543020</pub-id><?supplied-pmid 11743766?><pub-id pub-id-type="pmid">11743766</pub-id></element-citation></ref><ref id="B10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aruoma</surname><given-names>O. I.</given-names></name></person-group><article-title>Free radicals, oxidative stress and antioxidants in human health and disease</article-title><source><italic toggle="yes">Journal of the American Oil Chemists' Society</italic></source><year>1998</year><volume>75</volume><issue>2</issue><fpage>199</fpage><lpage>212</lpage><pub-id pub-id-type="doi">10.1007/s11746-998-0032-9</pub-id><pub-id pub-id-type="other">2-s2.0-0031996717</pub-id><?supplied-pmid 32287334?><pub-id pub-id-type="pmid">32287334</pub-id></element-citation></ref><ref id="B11"><label>11</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Gilham</surname><given-names>B.</given-names></name><name><surname>Papachristodoulou</surname><given-names>K.</given-names></name><name><surname>Thomas</surname><given-names>J. H.</given-names></name></person-group><source><italic toggle="yes">Wills&#x02019;Biochemical Basis of Medicine</italic></source><year>1997</year><publisher-loc>Oxford</publisher-loc><publisher-name>Butterworth-Heinemenn</publisher-name></element-citation></ref><ref id="B12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lewis</surname><given-names>D. A.</given-names></name></person-group><article-title>Anti-inflammatory drugs from plant and marine sources</article-title><source><italic toggle="yes">Agents and Actions Supplements</italic></source><year>1989</year><volume>27</volume><fpage>3</fpage><lpage>373</lpage><?supplied-pmid 2784931?><pub-id pub-id-type="pmid">2784931</pub-id></element-citation></ref><ref id="B13"><label>13</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Cotran</surname><given-names>R. S.</given-names></name><name><surname>Kumar</surname><given-names>V.</given-names></name><name><surname>Robbins</surname><given-names>S. L.</given-names></name></person-group><source><italic toggle="yes">Robbins, pathologic basis of disease</italic></source><year>1994</year><edition>9th</edition><publisher-loc>Philadelphia</publisher-loc><publisher-name>W.B. Saunders Company</publisher-name></element-citation></ref><ref id="B14"><label>14</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Xiao</surname><given-names>H.</given-names></name></person-group><article-title>Therapeutic effects and the underlying mechanisms of qing-dai powder against experimental colitis in mice</article-title><source><italic toggle="yes">thesis of doctor of philosophy</italic></source><year>2015</year><publisher-name>Hong Kong Baptist University</publisher-name></element-citation></ref><ref id="B15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Solomon</surname><given-names>L.</given-names></name><name><surname>Mansor</surname><given-names>S.</given-names></name><name><surname>Mallon</surname><given-names>P.</given-names></name><etal/></person-group><article-title>The dextran sulphate sodium (DSS) model of colitis: an overview</article-title><source><italic toggle="yes">Comparative Clinical Pathology</italic></source><year>2010</year><volume>19</volume><issue>3</issue><fpage>235</fpage><lpage>239</lpage><pub-id pub-id-type="doi">10.1007/s00580-010-0979-4</pub-id><pub-id pub-id-type="other">2-s2.0-77952099431</pub-id></element-citation></ref><ref id="B16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mizoguchi</surname><given-names>A.</given-names></name></person-group><article-title>Animal models of inflammatory bowel disease</article-title><source><italic toggle="yes">Progress in Molecular Biology and Translational Science</italic></source><year>2011</year><volume>105</volume><fpage>263</fpage><lpage>320</lpage></element-citation></ref><ref id="B17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fyhrquist</surname><given-names>P.</given-names></name><name><surname>Mwasumbi</surname><given-names>L.</given-names></name><name><surname>H&#x000e6;ggstrom</surname><given-names>C. A.</given-names></name><name><surname>Vuorela</surname><given-names>H.</given-names></name><name><surname>Hiltunen</surname><given-names>R.</given-names></name><name><surname>Vuorela</surname><given-names>P.</given-names></name></person-group><article-title>Antifungal activity of selected species of Terminalia, Pteleopsis and Combretum (Combretaceae) collected in Tanzania</article-title><source><italic toggle="yes">Pharmaceutical Biology</italic></source><year>2008</year><volume>42</volume><issue>4&#x02013;5</issue><fpage>308</fpage><lpage>317</lpage></element-citation></ref><ref id="B18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dawe</surname><given-names>A.</given-names></name><name><surname>Wabo Fotso</surname><given-names>K. G. D.</given-names></name><name><surname>Bankeu Kezetas</surname><given-names>J. J.</given-names></name><name><surname>Fawaia</surname><given-names>Y.</given-names></name><name><surname>Alid Shaiq</surname><given-names>M.</given-names></name><name><surname>Ngadjuie Tchaleu</surname><given-names>B.</given-names></name></person-group><article-title>Combretins A and B, new cycloartane-type triterpenes fromCombretum fragrans</article-title><source><italic toggle="yes">Helvetica Chimica Acta</italic></source><year>2016</year><volume>99</volume><issue>8</issue><fpage>617</fpage><lpage>620</lpage><pub-id pub-id-type="doi">10.1002/hlca.201600053</pub-id><pub-id pub-id-type="other">2-s2.0-84982224468</pub-id></element-citation></ref><ref id="B19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mbiantcha</surname><given-names>M.</given-names></name><name><surname>Almas</surname><given-names>J.</given-names></name><name><surname>Dawe</surname><given-names>A.</given-names></name><name><surname>Faheem</surname><given-names>A.</given-names></name><name><surname>Sidra</surname><given-names>Z.</given-names></name></person-group><article-title>Analgesic, anti-inflammatory and anticancer activities of Combretin A and Combretin B isolated from <italic>Combretum fragrans</italic> F. HOFFM (Combretaceae) leaves</article-title><source><italic toggle="yes">Inflammopharmacology</italic></source><year>2018</year><volume>26</volume><issue>6</issue><fpage>1429</fpage><lpage>1440</lpage><pub-id pub-id-type="doi">10.1007/s10787-017-0421-5</pub-id><pub-id pub-id-type="other">2-s2.0-85034605155</pub-id><?supplied-pmid 29159717?><pub-id pub-id-type="pmid">29159717</pub-id></element-citation></ref><ref id="B20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mbiantcha</surname><given-names>M.</given-names></name><name><surname>Khalid</surname><given-names>R.</given-names></name><name><surname>Dawe</surname><given-names>A.</given-names></name><etal/></person-group><article-title>Antihypernociceptive and neuroprotective effects of Combretin A and Combretin B on streptozotocin-induced diabetic neuropathy in mice</article-title><source><italic toggle="yes">Naunyn-Schmiedeberg's Archives of Pharmacology</italic></source><year>2019</year><volume>392</volume><issue>6</issue><fpage>697</fpage><lpage>713</lpage><pub-id pub-id-type="doi">10.1007/s00210-019-01626-1</pub-id><pub-id pub-id-type="other">2-s2.0-85061480974</pub-id><?supplied-pmid 30759263?><pub-id pub-id-type="pmid">30759263</pub-id></element-citation></ref><ref id="B21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Djuichou Nguemnang</surname><given-names>S. F.</given-names></name><name><surname>Tsafack</surname><given-names>E. G.</given-names></name><name><surname>Mbiantcha</surname><given-names>M.</given-names></name><etal/></person-group><article-title>In vitro anti-inflammatory and in vivo antiarthritic activities of aqueous and ethanolic extracts of Dissotis thollonii Cogn. (Melastomataceae) in rats</article-title><source><italic toggle="yes">Evidence-Based Complementary and Alternative Medicine</italic></source><year>2019</year><volume>2019</volume><fpage>17</fpage><pub-id pub-id-type="doi">10.1155/2019/3612481</pub-id><pub-id pub-id-type="publisher-id">3612481</pub-id></element-citation></ref><ref id="B22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Padmanabhan</surname><given-names>P.</given-names></name><name><surname>Jangle</surname><given-names>S. N.</given-names></name></person-group><article-title>Evaluation of in-vitro anti-inflammatory activity of herbal preparation, a combination of four medicinal plants</article-title><source><italic toggle="yes">International Journal of Basic and Applied Medical Sciences</italic></source><year>2012</year><volume>2</volume><issue>1</issue><fpage>109</fpage><lpage>116</lpage></element-citation></ref><ref id="B23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Viji</surname><given-names>V.</given-names></name><name><surname>Helen</surname><given-names>A.</given-names></name></person-group><article-title>Inhibition of lipoxygenases and cyclooxygenase-2 enzymes by extracts isolated from Bacopa monniera (L.) Wettst</article-title><source><italic toggle="yes">Journal of Ethnopharmacology</italic></source><year>2008</year><volume>118</volume><issue>2</issue><fpage>305</fpage><lpage>311</lpage><pub-id pub-id-type="doi">10.1016/j.jep.2008.04.017</pub-id><pub-id pub-id-type="other">2-s2.0-45449105529</pub-id><?supplied-pmid 18534796?><pub-id pub-id-type="pmid">18534796</pub-id></element-citation></ref><ref id="B24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shah</surname><given-names>N. A.</given-names></name><name><surname>Khan</surname><given-names>M. R.</given-names></name><name><surname>Ahmad</surname><given-names>B.</given-names></name><name><surname>Noureen</surname><given-names>F.</given-names></name><name><surname>Rashid</surname><given-names>U.</given-names></name><name><surname>Khan</surname><given-names>R. A.</given-names></name></person-group><article-title>Investigation on flavonoid composition and anti free radical potential of Sida cordata</article-title><source><italic toggle="yes">BMC Complementary and Alternative Medicine</italic></source><year>2013</year><volume>13</volume><issue>1</issue><pub-id pub-id-type="doi">10.1186/1472-6882-13-276</pub-id><pub-id pub-id-type="other">2-s2.0-84886879363</pub-id></element-citation></ref><ref id="B25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Re</surname><given-names>R.</given-names></name><name><surname>Pellegrini</surname><given-names>N.</given-names></name><name><surname>Proteggente</surname><given-names>A.</given-names></name><name><surname>Pannala</surname><given-names>A.</given-names></name><name><surname>Yang</surname><given-names>M.</given-names></name><name><surname>Rice-Evans</surname><given-names>C.</given-names></name></person-group><article-title>Antioxidant activity applying an improved ABTS radical cation decolorization assay</article-title><source><italic toggle="yes">Free Radical Biology and Medicine</italic></source><year>1999</year><volume>26</volume><issue>9-10</issue><fpage>1231</fpage><lpage>1237</lpage><pub-id pub-id-type="doi">10.1016/S0891-5849(98)00315-3</pub-id><pub-id pub-id-type="other">2-s2.0-0032982508</pub-id><pub-id pub-id-type="pmid">10381194</pub-id></element-citation></ref><ref id="B26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Benzie</surname><given-names>I. F. F.</given-names></name><name><surname>Strain</surname><given-names>J. J.</given-names></name></person-group><article-title>[2] Ferric reducing/antioxidant power assay: direct measure of total antioxidant activity of biological fluids and modified version for simultaneous measurement of total antioxidant power and ascorbic acid concentration</article-title><source><italic toggle="yes">Methods in Enzymology</italic></source><year>1999</year><volume>299</volume><fpage>15</fpage><lpage>27</lpage><pub-id pub-id-type="doi">10.1016/S0076-6879(99)99005-5</pub-id><pub-id pub-id-type="other">2-s2.0-0031729201</pub-id><pub-id pub-id-type="pmid">9916193</pub-id></element-citation></ref><ref id="B27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anoop</surname><given-names>M. V.</given-names></name><name><surname>Bindu</surname><given-names>A. R.</given-names></name></person-group><article-title>In-vitro anti-inflammatory activity studies on Syzygium zeylanicum (L.) DC leaves</article-title><source><italic toggle="yes">International Journal of Pharmaceutical Review and Research</italic></source><year>2015</year><volume>4</volume><issue>8</issue><fpage>18</fpage><lpage>27</lpage></element-citation></ref><ref id="B28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rodriguez-Canales</surname><given-names>M.</given-names></name><name><surname>Jimenez-Rivas</surname><given-names>R.</given-names></name><name><surname>Canales-Martinez</surname><given-names>M. M.</given-names></name><etal/></person-group><article-title>Protective effect of Amphipterygium adstringens extract on dextran sulphate sodium-induced ulcerative colitis in mice</article-title><source><italic toggle="yes">Mediators of Inflammation</italic></source><year>2016</year><volume>2016</volume><fpage>12</fpage><pub-id pub-id-type="publisher-id">8543561</pub-id><pub-id pub-id-type="doi">10.1155/2016/8543561</pub-id><pub-id pub-id-type="other">2-s2.0-84986301141</pub-id><?supplied-pmid 27635116?><pub-id pub-id-type="pmid">27635116</pub-id></element-citation></ref><ref id="B29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Adjouzem</surname><given-names>C. F.</given-names></name><name><surname>Gilbert</surname><given-names>A.</given-names></name><name><surname>Mbiantcha</surname><given-names>M.</given-names></name><etal/></person-group><article-title>Effects of aqueous and methanolic extracts of stem bark of Alstonia boonei De wild. (Apocynaceae) on dextran sodium sulfate-induced ulcerative colitis in Wistar rats</article-title><source><italic toggle="yes">Evidence-Based Complementary and Alternative Medicine</italic></source><year>2020</year><volume>2020</volume><fpage>15</fpage><pub-id pub-id-type="publisher-id">4918453</pub-id><pub-id pub-id-type="doi">10.1155/2020/4918453</pub-id><?supplied-pmid 32565862?><pub-id pub-id-type="pmid">32565862</pub-id></element-citation></ref><ref id="B30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mizushima</surname><given-names>Y.</given-names></name><name><surname>Kobayashi</surname><given-names>M.</given-names></name></person-group><article-title>Interaction of antiinflammatory drugs with serum proteins, especially with some biologically active proteins</article-title><source><italic toggle="yes">Journal of Pharmaceutical Sciences</italic></source><year>1968</year><volume>20</volume><fpage>169</fpage><lpage>173</lpage></element-citation></ref><ref id="B31"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grant</surname><given-names>N. H.</given-names></name><name><surname>Alburn</surname><given-names>H. E.</given-names></name><name><surname>Kryzanauskas</surname><given-names>C.</given-names></name></person-group><article-title>Stabilization of serum albumin by anti-inflammatory drugs</article-title><source><italic toggle="yes">Biochemical Pharmacology</italic></source><year>1970</year><volume>19</volume><issue>3</issue><fpage>715</fpage><lpage>722</lpage><pub-id pub-id-type="doi">10.1016/0006-2952(70)90234-0</pub-id><pub-id pub-id-type="other">2-s2.0-0014746748</pub-id><?supplied-pmid 4101192?><pub-id pub-id-type="pmid">4101192</pub-id></element-citation></ref><ref id="B32"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bailey-Shaw</surname><given-names>Y. A.</given-names></name><name><surname>Williams</surname><given-names>L. A. D.</given-names></name><name><surname>Green</surname><given-names>C. E.</given-names></name><name><surname>Rodney</surname><given-names>S.</given-names></name><name><surname>Smith</surname><given-names>A. M.</given-names></name></person-group><article-title>In-vitro evaluation of the anti-inflammatory potential of selected Jamaican plant extracts using the bovine serum albumin protein denaturation assay</article-title><source><italic toggle="yes">International Journal of Pharmaceutical Sciences Review and Research</italic></source><year>2017</year><volume>47</volume><issue>1</issue><fpage>145</fpage><lpage>153</lpage></element-citation></ref><ref id="B33"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mannan</surname><given-names>M. M.</given-names></name><name><surname>Maridass</surname><given-names>M.</given-names></name><name><surname>Victor</surname><given-names>B.</given-names></name></person-group><article-title>A review on the potential uses of ferns</article-title><source><italic toggle="yes">Ethnobotanical Leaflets</italic></source><year>2008</year><volume>12</volume><fpage>281</fpage><lpage>285</lpage></element-citation></ref><ref id="B34"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ghosh</surname><given-names>G.</given-names></name><name><surname>Panda</surname><given-names>P.</given-names></name><name><surname>Rath</surname><given-names>M.</given-names></name><name><surname>Pal</surname><given-names>A.</given-names></name><name><surname>Sharma</surname><given-names>T.</given-names></name><name><surname>Das</surname><given-names>D.</given-names></name></person-group><article-title>GC-MS analysis of bioactive compounds in the methanol extract of <italic>Clerodendrum viscosum</italic> leaves</article-title><source><italic toggle="yes">Pharmacognosy Research</italic></source><year>2015</year><volume>7</volume><issue>1</issue><fpage>110</fpage><lpage>113</lpage><pub-id pub-id-type="doi">10.4103/0974-8490.147223</pub-id><pub-id pub-id-type="other">2-s2.0-84919968496</pub-id><?supplied-pmid 25598644?><pub-id pub-id-type="pmid">25598644</pub-id></element-citation></ref><ref id="B35"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Frey</surname><given-names>F. M.</given-names></name><name><surname>Meyers</surname><given-names>R.</given-names></name></person-group><article-title>Antibacterial activity of traditional medicinal plants used by Haudenosaunee peoples of New York State</article-title><source><italic toggle="yes">BMC Complementary and Alternative Medicine</italic></source><year>2010</year><volume>10</volume><issue>1</issue><pub-id pub-id-type="doi">10.1186/1472-6882-10-64</pub-id><pub-id pub-id-type="other">2-s2.0-78049388973</pub-id></element-citation></ref><ref id="B36"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gierse</surname><given-names>J. K.</given-names></name><name><surname>Koboldt</surname><given-names>C. M.</given-names></name><name><surname>Walker</surname><given-names>M. C.</given-names></name><name><surname>Seibert</surname><given-names>K.</given-names></name><name><surname>Isakson</surname><given-names>P. C.</given-names></name></person-group><article-title>Kinetic basis for selective inhibition of cyclo-oxygenases</article-title><source><italic toggle="yes">Biochemical Journal</italic></source><year>1999</year><volume>339</volume><issue>3</issue><fpage>607</fpage><lpage>614</lpage><pub-id pub-id-type="doi">10.1042/bj3390607</pub-id><pub-id pub-id-type="pmid">10215599</pub-id></element-citation></ref><ref id="B37"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Prusakiewicz</surname><given-names>J. J.</given-names></name><name><surname>Duggan</surname><given-names>K. C.</given-names></name><name><surname>Rouzer</surname><given-names>C. A.</given-names></name><name><surname>Marnett</surname><given-names>L. J.</given-names></name></person-group><article-title>Differential sensitivity and mechanism of inhibition of COX-2 oxygenation of arachidonic acid and 2-arachidonoylglycerol by ibuprofen and mefenamic acid</article-title><source><italic toggle="yes">Biochemistry</italic></source><year>2009</year><volume>48</volume><issue>31</issue><fpage>7353</fpage><lpage>7355</lpage><pub-id pub-id-type="doi">10.1021/bi900999z</pub-id><pub-id pub-id-type="other">2-s2.0-68249100483</pub-id><?supplied-pmid 19603831?><pub-id pub-id-type="pmid">19603831</pub-id></element-citation></ref><ref id="B38"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Botting</surname><given-names>R. M.</given-names></name></person-group><article-title>Inhibitors of cyclooxygenases: mechanisms, selectivity and uses</article-title><source><italic toggle="yes">Journal of physiology and pharmacology</italic></source><year>2006</year><volume>57</volume><issue>5</issue><fpage>113</fpage><lpage>124</lpage></element-citation></ref><ref id="B39"><label>39</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsuzuki</surname><given-names>K.</given-names></name><name><surname>Ohashi</surname><given-names>A.</given-names></name><name><surname>Arai</surname><given-names>Y.</given-names></name><etal/></person-group><article-title>Triterpenoids from <italic>Adiantum caudatum</italic></article-title><source><italic toggle="yes">Phytochemistry</italic></source><year>2001</year><volume>58</volume><issue>2</issue><fpage>363</fpage><lpage>367</lpage><pub-id pub-id-type="doi">10.1016/S0031-9422(01)00198-4</pub-id><pub-id pub-id-type="other">2-s2.0-0035801688</pub-id><pub-id pub-id-type="pmid">11551565</pub-id></element-citation></ref><ref id="B40"><label>40</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liang</surname><given-names>N.</given-names></name><name><surname>Kitts</surname><given-names>D.</given-names></name></person-group><article-title>Antioxidant property of coffee components: assessment of methods that define mechanisms of action</article-title><source><italic toggle="yes">Molecules</italic></source><year>2014</year><volume>19</volume><issue>11</issue><fpage>19180</fpage><lpage>19208</lpage><pub-id pub-id-type="doi">10.3390/molecules191119180</pub-id><pub-id pub-id-type="other">2-s2.0-84915820693</pub-id><?supplied-pmid 25415479?><pub-id pub-id-type="pmid">25415479</pub-id></element-citation></ref><ref id="B41"><label>41</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ahmed</surname><given-names>D.</given-names></name><name><surname>Mir</surname><given-names>H.</given-names></name></person-group><article-title>Study of antioxidant, anti-protease and anti-urease potential of Schiff bases of acetophenone with different amines</article-title><source><italic toggle="yes">Journal of the Chemical Society of Pakistan</italic></source><year>2014</year><volume>36</volume><fpage>915</fpage><lpage>921</lpage></element-citation></ref><ref id="B42"><label>42</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Balakrishnan</surname><given-names>N.</given-names></name><name><surname>Panda</surname><given-names>A. B.</given-names></name><name><surname>Raj</surname><given-names>N. R.</given-names></name><name><surname>Shrivastava</surname><given-names>A.</given-names></name><name><surname>Prathani</surname><given-names>R.</given-names></name></person-group><article-title>The evaluation of nitric oxide scavenging activity of <italic>Acalypha indica</italic> Linn root</article-title><source><italic toggle="yes">Asian Journal of Research in Chemistry</italic></source><year>2009</year><volume>2</volume><fpage>148</fpage><lpage>150</lpage></element-citation></ref><ref id="B43"><label>43</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Strohmayer</surname><given-names>E. A.</given-names></name><name><surname>Krakoff</surname><given-names>L. R.</given-names></name></person-group><article-title>Glucocorticoids and cardiovascular risk factors</article-title><source><italic toggle="yes">Endocrinology and Metabolism Clinics of North America</italic></source><year>2011</year><volume>28</volume><fpage>409</fpage><lpage>427</lpage></element-citation></ref><ref id="B44"><label>44</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>S. H.</given-names></name></person-group><article-title>Intestinal permeability regulation by tight junction: implication on inflammatory bowel diseases</article-title><source><italic toggle="yes">Intestinal Research</italic></source><year>2015</year><volume>13</volume><issue>1</issue><fpage>11</fpage><lpage>18</lpage><pub-id pub-id-type="doi">10.5217/ir.2015.13.1.11</pub-id><?supplied-pmid 25691839?><pub-id pub-id-type="pmid">25691839</pub-id></element-citation></ref><ref id="B45"><label>45</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Francescone</surname><given-names>R.</given-names></name><name><surname>Hou</surname><given-names>V.</given-names></name><name><surname>Grivennikov</surname><given-names>S. I.</given-names></name></person-group><article-title>Cytokines, IBD, and colitis-associated cancer</article-title><source><italic toggle="yes">Inflammatory bowel disease</italic></source><year>2015</year><volume>21</volume><issue>2</issue><fpage>409</fpage><lpage>418</lpage><pub-id pub-id-type="doi">10.1097/MIB.0000000000000236</pub-id><pub-id pub-id-type="other">2-s2.0-84927727735</pub-id><?supplied-pmid 25563695?><pub-id pub-id-type="pmid">25563695</pub-id></element-citation></ref><ref id="B46"><label>46</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Colitis-Pathophysiology</surname><given-names>U.</given-names></name></person-group><article-title>Inflammatory bowel disease part I: ulcerative colitis&#x02013;pathophysiology and conventional and alternative treatment options</article-title><source><italic toggle="yes">Alternative Medicine Review</italic></source><year>2003</year><volume>8</volume><issue>3</issue><fpage>247</fpage><lpage>283</lpage><pub-id pub-id-type="pmid">12946238</pub-id></element-citation></ref><ref id="B47"><label>47</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mart&#x000ed;n</surname><given-names>A. R.</given-names></name><name><surname>Villegas</surname><given-names>I.</given-names></name><name><surname>S&#x000e1;nchez-Hidalgo</surname><given-names>M.</given-names></name><name><surname>de la Lastra</surname><given-names>C. A.</given-names></name></person-group><article-title>The effects of resveratrol, a phytoalexin derived from red wines, on chronic inflammation induced in an experimentally induced colitis model</article-title><source><italic toggle="yes">British Journal of Pharmacology</italic></source><year>2006</year><volume>147</volume><issue>8</issue><fpage>873</fpage><lpage>885</lpage><pub-id pub-id-type="doi">10.1038/sj.bjp.0706469</pub-id><pub-id pub-id-type="other">2-s2.0-33646572516</pub-id><?supplied-pmid 16474422?><pub-id pub-id-type="pmid">16474422</pub-id></element-citation></ref><ref id="B48"><label>48</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mo</surname><given-names>Z. Z.</given-names></name><name><surname>Lin</surname><given-names>Z. X.</given-names></name><name><surname>Su</surname><given-names>Z. R.</given-names></name><etal/></person-group><article-title>Angelica sinensis supercritical fluid CO2 extract attenuates D-galactose-induced liver and kidney impairment in mice by suppressing oxidative stress and inflammation</article-title><source><italic toggle="yes">Journal of Medicinal Food</italic></source><year>2018</year><volume>21</volume><issue>9</issue><fpage>887</fpage><lpage>898</lpage><pub-id pub-id-type="doi">10.1089/jmf.2017.4061</pub-id><pub-id pub-id-type="other">2-s2.0-85053679052</pub-id><?supplied-pmid 30109956?><pub-id pub-id-type="pmid">30109956</pub-id></element-citation></ref><ref id="B49"><label>49</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kuwahara</surname><given-names>E.</given-names></name><name><surname>Murakami</surname><given-names>Y.</given-names></name><name><surname>Nakamura</surname><given-names>T.</given-names></name><etal/></person-group><article-title>Factors associated with exacerbation of newly diagnosed mild ulcerative colitis based on a nationwide registry in Japan</article-title><source><italic toggle="yes">Journal of Gastroenterology</italic></source><year>2017</year><volume>52</volume><issue>2</issue><fpage>185</fpage><lpage>193</lpage><pub-id pub-id-type="doi">10.1007/s00535-016-1209-x</pub-id><pub-id pub-id-type="other">2-s2.0-84963690419</pub-id><?supplied-pmid 27075755?><pub-id pub-id-type="pmid">27075755</pub-id></element-citation></ref><ref id="B50"><label>50</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bhattacharyya</surname><given-names>A.</given-names></name><name><surname>Chattopadhyay</surname><given-names>R.</given-names></name><name><surname>Mitra</surname><given-names>S.</given-names></name><name><surname>Crowe</surname><given-names>S. E.</given-names></name></person-group><article-title>Oxidative stress: an essential factor in the pathogenesis of gastrointestinal mucosal diseases</article-title><source><italic toggle="yes">Physiological Reviews</italic></source><year>2014</year><volume>94</volume><issue>2</issue><fpage>329</fpage><lpage>354</lpage><pub-id pub-id-type="doi">10.1152/physrev.00040.2012</pub-id><pub-id pub-id-type="other">2-s2.0-84899988992</pub-id><?supplied-pmid 24692350?><pub-id pub-id-type="pmid">24692350</pub-id></element-citation></ref><ref id="B51"><label>51</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rezaie</surname><given-names>A.</given-names></name><name><surname>Parker</surname><given-names>R. D.</given-names></name><name><surname>Abdollahi</surname><given-names>M.</given-names></name></person-group><article-title>Oxidative stress and pathogenesis of inflammatory bowel disease: an epiphenomenon or the cause?</article-title><source><italic toggle="yes">Digestive Diseases and Sciences</italic></source><year>2007</year><volume>52</volume><issue>9</issue><fpage>2015</fpage><lpage>2021</lpage><pub-id pub-id-type="doi">10.1007/s10620-006-9622-2</pub-id><pub-id pub-id-type="other">2-s2.0-34547851729</pub-id><?supplied-pmid 17404859?><pub-id pub-id-type="pmid">17404859</pub-id></element-citation></ref><ref id="B52"><label>52</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Singh</surname><given-names>U. P.</given-names></name><name><surname>Singh</surname><given-names>N. P.</given-names></name><name><surname>Singh</surname><given-names>B.</given-names></name><etal/></person-group><article-title>Resveratrol (trans-3,5,4&#x02032;-trihydroxystilbene) induces silent mating type information regulation-1 and down-regulates nuclear transcription factor-<italic>&#x003ba;</italic>B activation to abrogate dextran sulfate sodium-induced colitis</article-title><source><italic toggle="yes">Journal of Pharmacology and Experimental Therapeutics</italic></source><year>2010</year><volume>332</volume><issue>3</issue><fpage>829</fpage><lpage>839</lpage><pub-id pub-id-type="doi">10.1124/jpet.109.160838</pub-id><pub-id pub-id-type="other">2-s2.0-77249089947</pub-id><?supplied-pmid 19940103?><pub-id pub-id-type="pmid">19940103</pub-id></element-citation></ref><ref id="B53"><label>53</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Farombi</surname><given-names>E. O.</given-names></name><name><surname>Adedara</surname><given-names>I. A.</given-names></name><name><surname>Awoyemi</surname><given-names>O. V.</given-names></name><etal/></person-group><article-title>Dietary protocatechuic acid ameliorates dextran sulphate sodium-induced ulcerative colitis and hepatotoxicity in rats</article-title><source><italic toggle="yes">Food &#x00026; Function</italic></source><year>2016</year><volume>7</volume><issue>2</issue><fpage>913</fpage><lpage>921</lpage><pub-id pub-id-type="doi">10.1039/C5FO01228G</pub-id><pub-id pub-id-type="other">2-s2.0-84959378502</pub-id><?supplied-pmid 26691887?><pub-id pub-id-type="pmid">26691887</pub-id></element-citation></ref></ref-list></back><floats-group><fig id="fig1" orientation="portrait" position="float"><label>Figure 1</label><caption><p>Antioxidant capacity of Combretin A and Combretin B on ABTS<sup>&#x02022;+</sup> radical assay (a) expressed as percentage activity, and on DPPH assay (b) as a function of time for 30&#x02009;min and FRAP assay in terms of Ascorbic Acid Equivalents (AAE). Each point represents the mean of three replications.</p></caption><graphic xlink:href="GRP2020-4253174.001"/></fig><fig id="fig2" orientation="portrait" position="float"><label>Figure 2</label><caption><p>Effect of Combretin A and Combretin B on relative body weight (a), disease activity index (DAI) (b), and stool state (c) in DSS-induced colitis in rat. Values are expressed as mean &#x000b1; SEM for six animals and analyses by two-way ANOVA followed by Bonferroni post hoc test. <sup>A</sup><italic>p</italic> &#x0003c; 0.05, <sup>B</sup><italic>p</italic> &#x0003c; 0.01, <sup>C</sup><italic>p</italic> &#x0003c; 0.001: significant difference compared with negative control;<italic><sup>&#x003b1;</sup>p</italic> &#x0003c; 0.05, <italic><sup>&#x003b2;</sup>p</italic> &#x0003c; 0.01, <italic><sup>&#x003bb;</sup>p</italic> &#x0003c; 0.001: significant difference compared with normal control.</p></caption><graphic xlink:href="GRP2020-4253174.002"/></fig><fig id="fig3" orientation="portrait" position="float"><label>Figure 3</label><caption><p>Effect of Combretin A and Combretin B on colon length in DSS-induced colitis in rats. Mice colons were isolated 10 days after DSS administration, and their lengths were measured. Values are expressed as mean &#x000b1; SEM for six animals and analyses by one-way ANOVA followed by Tukey post hoc test; <sup>B</sup><italic>p</italic> &#x0003c; 0.01, <sup>C</sup><italic>p</italic> &#x0003c; 0.001: significant difference compared with negative control (Neg. C);<italic><sup>&#x003b1;</sup>p</italic> &#x0003c; 0.05, <italic><sup>&#x003b2;</sup>p</italic> &#x0003c; 0.01, <italic><sup>&#x003bb;</sup>p</italic> &#x0003c; 0.001: significant difference compared with normal control (NC). CA: Combretin A; CB: Combretin B.</p></caption><graphic xlink:href="GRP2020-4253174.003"/></fig><fig id="fig4" orientation="portrait" position="float"><label>Figure 4</label><caption><p>Effect of Combretin A and Combretin B on histopathological score in DSS-induced colitis in rat. (a) Representative hematoxylin and eosin (H&#x00026;E)-stained distal colon sections and (b) the histologic scores of rats. Values are expressed as mean &#x000b1; SEM for six animals and analyses by one-way ANOVA followed by the Tukey post hoc test; <sup>C</sup><italic>p</italic> &#x0003c; 0.001: significant difference compared with negative control (Neg. C); <italic><sup>&#x003bb;</sup>p</italic> &#x0003c; 0.001: significant difference compared with normal control (NC). CA: Combretin A; CB: Combretin B.</p></caption><graphic xlink:href="GRP2020-4253174.004"/></fig><table-wrap id="tab1" orientation="portrait" position="float"><label>Table 1</label><caption><p>Effect of Combretin A and Combretin B on protein denaturation, cyclooxygenase (COX), and 5-lipoxygenase (LOX) inhibition.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="2" colspan="1">Treatment</th><th align="center" rowspan="2" colspan="1">Dose (<italic>&#x003bc;</italic>g/mL)</th><th align="center" colspan="3" rowspan="1">Activity</th><th align="center" colspan="3" rowspan="1">Inhibition (%)</th></tr><tr><th align="center" rowspan="1" colspan="1">Protein denaturation</th><th align="center" rowspan="1" colspan="1">COX</th><th align="center" rowspan="1" colspan="1">5-LOX</th><th align="center" rowspan="1" colspan="1">Protein denaturation</th><th align="center" rowspan="1" colspan="1">COX</th><th align="center" rowspan="1" colspan="1">5-LOX</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Control</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">0.518 &#x000b1; 0.004</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">-</td></tr><tr><td align="left" rowspan="4" colspan="1">Diclofenac</td><td align="center" rowspan="1" colspan="1">100</td><td align="center" rowspan="1" colspan="1">0.133 &#x000b1; 0.002<sup>c</sup></td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">74.41</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">-</td></tr><tr><td align="center" rowspan="1" colspan="1">200</td><td align="center" rowspan="1" colspan="1">0.121 &#x000b1; 0.002<sup>c</sup></td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">76.72</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">-</td></tr><tr><td align="center" rowspan="1" colspan="1">500</td><td align="center" rowspan="1" colspan="1">0.133 &#x000b1; 0.002<sup>c</sup></td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">81.48</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">-</td></tr><tr><td align="center" rowspan="1" colspan="1">1000</td><td align="center" rowspan="1" colspan="1">0.056 &#x000b1; 0.001<sup>c</sup></td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">89.19</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">-</td></tr><tr><td align="left" rowspan="4" colspan="1">Ibuprofen</td><td align="center" rowspan="1" colspan="1">100</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">0.11 &#x000b1; 0.006</td><td align="center" rowspan="1" colspan="1">0.232 &#x000b1; 0.022</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">83.51</td><td align="center" rowspan="1" colspan="1">83.16</td></tr><tr><td align="center" rowspan="1" colspan="1">200</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">0.018 &#x000b1; 0.001<sup>c</sup></td><td align="center" rowspan="1" colspan="1">0.038 &#x000b1; 0.001<sup>c</sup></td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">88.79</td><td align="center" rowspan="1" colspan="1">87.41</td></tr><tr><td align="center" rowspan="1" colspan="1">500</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">0.011 &#x000b1; 0.44<sup>c</sup></td><td align="center" rowspan="1" colspan="1">0.029 &#x000b1; 0.005<sup>c</sup></td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">93.06</td><td align="center" rowspan="1" colspan="1">91.36</td></tr><tr><td align="center" rowspan="1" colspan="1">1000</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">0.007 &#x000b1; 0.001<sup>c</sup></td><td align="center" rowspan="1" colspan="1">0.021 &#x000b1; 0.006<sup>c</sup></td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">97.51</td><td align="center" rowspan="1" colspan="1">95.65</td></tr><tr><td align="left" rowspan="4" colspan="1">Combretin A</td><td align="center" rowspan="1" colspan="1">100</td><td align="center" rowspan="1" colspan="1">0.298 &#x000b1; 0.011<sup>c</sup></td><td align="center" rowspan="1" colspan="1">0.055 &#x000b1; 0.009<sup>b</sup></td><td align="center" rowspan="1" colspan="1">0.110 &#x000b1; 0.009<sup>b</sup></td><td align="center" rowspan="1" colspan="1">42.49</td><td align="center" rowspan="1" colspan="1">47.58</td><td align="center" rowspan="1" colspan="1">44.25</td></tr><tr><td align="center" rowspan="1" colspan="1">200</td><td align="center" rowspan="1" colspan="1">0.255 &#x000b1; 0.032<sup>c</sup></td><td align="center" rowspan="1" colspan="1">0.041 &#x000b1; 0.001<sup>c</sup></td><td align="center" rowspan="1" colspan="1">0.075 &#x000b1; 0.007<sup>c</sup></td><td align="center" rowspan="1" colspan="1">50.92</td><td align="center" rowspan="1" colspan="1">59.58</td><td align="center" rowspan="1" colspan="1">60.87</td></tr><tr><td align="center" rowspan="1" colspan="1">500</td><td align="center" rowspan="1" colspan="1">0.231 &#x000b1; 0.023<sup>c</sup></td><td align="center" rowspan="1" colspan="1">0.037 &#x000b1; 0.003<sup>c</sup></td><td align="center" rowspan="1" colspan="1">0.064 &#x000b1; 0.003<sup>c</sup></td><td align="center" rowspan="1" colspan="1">55.41</td><td align="center" rowspan="1" colspan="1">63.06</td><td align="left" rowspan="1" colspan="1">67.64</td></tr><tr><td align="center" rowspan="1" colspan="1">1000</td><td align="center" rowspan="1" colspan="1">0.187 &#x000b1; 0.007<sup>c</sup></td><td align="center" rowspan="1" colspan="1">0.029 &#x000b1; 0.001<sup>c</sup></td><td align="center" rowspan="1" colspan="1">0.046 &#x000b1; 0.003<sup>c</sup></td><td align="center" rowspan="1" colspan="1">63.93</td><td align="center" rowspan="1" colspan="1">71.92</td><td align="center" rowspan="1" colspan="1">76.68</td></tr><tr><td align="left" rowspan="4" colspan="1">Combretin B</td><td align="center" rowspan="1" colspan="1">100</td><td align="center" rowspan="1" colspan="1">0.211 &#x000b1; 0.005<sup>c</sup></td><td align="center" rowspan="1" colspan="1">0.039 &#x000b1; 0.001<sup>c</sup></td><td align="center" rowspan="1" colspan="1">0.073 &#x000b1; 0.006<sup>c</sup></td><td align="center" rowspan="1" colspan="1">59.23</td><td align="center" rowspan="1" colspan="1">61.94</td><td align="center" rowspan="1" colspan="1">62.22</td></tr><tr><td align="center" rowspan="1" colspan="1">200</td><td align="center" rowspan="1" colspan="1">0.158 &#x000b1; 0.012<sup>c</sup></td><td align="center" rowspan="1" colspan="1">0.030 &#x000b1; 0.003<sup>c</sup></td><td align="center" rowspan="1" colspan="1">0.058 &#x000b1; 0.007<sup>c</sup></td><td align="center" rowspan="1" colspan="1">69.44</td><td align="center" rowspan="1" colspan="1">71.04</td><td align="center" rowspan="1" colspan="1">69.77</td></tr><tr><td align="center" rowspan="1" colspan="1">500</td><td align="center" rowspan="1" colspan="1">0.115 &#x000b1; 0.003<sup>c</sup></td><td align="center" rowspan="1" colspan="1">0.020 &#x000b1; 0.001<sup>c</sup></td><td align="center" rowspan="1" colspan="1">0.038 &#x000b1; 0.009<sup>c</sup></td><td align="center" rowspan="1" colspan="1">77.82</td><td align="center" rowspan="1" colspan="1">80.58</td><td align="center" rowspan="1" colspan="1">81.15</td></tr><tr><td align="center" rowspan="1" colspan="1">1000</td><td align="center" rowspan="1" colspan="1">0.063 &#x000b1; 0.005<sup>c</sup></td><td align="center" rowspan="1" colspan="1">0.011 &#x000b1; 0.002<sup>c</sup></td><td align="center" rowspan="1" colspan="1">0.018 &#x000b1; 0.005<sup>c</sup></td><td align="center" rowspan="1" colspan="1">87.78</td><td align="center" rowspan="1" colspan="1">89.59</td><td align="center" rowspan="1" colspan="1">91.21</td></tr></tbody></table><table-wrap-foot><fn><p>Each value represents the mean &#x000b1; SEM;<sup>b</sup><italic>p</italic> &#x0003c; 0.001, <sup>c</sup><italic>p</italic> &#x0003c; 0.001: significant difference compared to the control group. The percentage values were obtained using various concentrations of test compounds, and readings are presented as the mean of triplicates.</p></fn></table-wrap-foot></table-wrap><table-wrap id="tab2" orientation="portrait" position="float"><label>Table 2</label><caption><p>Effect of Combretin A and Combretin B on nitric oxide scavenging activity.</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="1" colspan="1"/><th align="center" rowspan="1" colspan="1">Concentration (mg/mL)</th><th align="center" rowspan="1" colspan="1">Absorbance (660&#x02009;nm)</th><th align="center" rowspan="1" colspan="1">Inhibition (%)</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Control</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">1.697 &#x000b1; 0.102</td><td align="center" rowspan="1" colspan="1">-</td></tr><tr><td align="left" rowspan="4" colspan="1">Vitamin C</td><td align="center" rowspan="1" colspan="1">0.1</td><td align="center" rowspan="1" colspan="1">0.800 &#x000b1; 0.058<sup>c</sup></td><td align="center" rowspan="1" colspan="1">52.86 &#x000b1; 1.90</td></tr><tr><td align="center" rowspan="1" colspan="1">0.25</td><td align="center" rowspan="1" colspan="1">0.400 &#x000b1; 0.029<sup>c</sup></td><td align="center" rowspan="1" colspan="1">76.27 &#x000b1; 2.22</td></tr><tr><td align="center" rowspan="1" colspan="1">0.5</td><td align="center" rowspan="1" colspan="1">0.193 &#x000b1; 0.006<sup>c</sup></td><td align="center" rowspan="1" colspan="1">88.56 &#x000b1; 0.47</td></tr><tr><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">0.099 &#x000b1; 0.009<sup>c</sup></td><td align="center" rowspan="1" colspan="1">94.08 &#x000b1; 0.80</td></tr><tr><td align="left" rowspan="4" colspan="1">Combretin A</td><td align="center" rowspan="1" colspan="1">0.1</td><td align="center" rowspan="1" colspan="1">1.136 &#x000b1; 0.055<sup>b</sup></td><td align="center" rowspan="1" colspan="1">32.28 &#x000b1; 6.65</td></tr><tr><td align="center" rowspan="1" colspan="1">0.25</td><td align="center" rowspan="1" colspan="1">0.873 &#x000b1; 0.062<sup>c</sup></td><td align="center" rowspan="1" colspan="1">48.41 &#x000b1; 3.34</td></tr><tr><td align="center" rowspan="1" colspan="1">0.5</td><td align="center" rowspan="1" colspan="1">0.780 &#x000b1; 0.075<sup>c</sup></td><td align="center" rowspan="1" colspan="1">54.22 &#x000b1; 1.59</td></tr><tr><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">0.608 &#x000b1; 0.092<sup>c</sup></td><td align="center" rowspan="1" colspan="1">64.54 &#x000b1; 3.16</td></tr><tr><td align="left" rowspan="4" colspan="1">Combretin B</td><td align="center" rowspan="1" colspan="1">0.1</td><td align="center" rowspan="1" colspan="1">0.719 &#x000b1; 0.071<sup>c</sup></td><td align="center" rowspan="1" colspan="1">57.79 &#x000b1; 2.18</td></tr><tr><td align="center" rowspan="1" colspan="1">0.25</td><td align="center" rowspan="1" colspan="1">0.467 &#x000b1; 0.034<sup>c</sup></td><td align="center" rowspan="1" colspan="1">72.09 &#x000b1; 3.45</td></tr><tr><td align="center" rowspan="1" colspan="1">0.5</td><td align="center" rowspan="1" colspan="1">0.380 &#x000b1; 0.015<sup>c</sup></td><td align="center" rowspan="1" colspan="1">77.48 &#x000b1; 1.38</td></tr><tr><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">0.137 &#x000b1; 0.032<sup>c</sup></td><td align="center" rowspan="1" colspan="1">91.81 &#x000b1; 2.16</td></tr></tbody></table><table-wrap-foot><fn><p>The values were obtained using various concentrations of test compounds, and reading is presented as mean &#x000b1; SEM of triplicates. <sup>b</sup><italic>p</italic> &#x0003c; 0.01 and <sup>c</sup><italic>p</italic> &#x0003c; 0.001 significantly different compared to control.</p></fn></table-wrap-foot></table-wrap></floats-group></article>